Isthmus Partners LLC Sells 5,486 Shares of Axcelis Technologies, Inc. (NASDAQ:ACLS)

Isthmus Partners LLC cut its holdings in shares of Axcelis Technologies, Inc. (NASDAQ:ACLS) by 16.5% during the 3rd quarter, HoldingsChannel.com reports. The fund owned 27,784 shares of the semiconductor company’s stock after selling 5,486 shares during the period. Isthmus Partners LLC’s holdings in Axcelis Technologies were worth $2,913,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in ACLS. Signaturefd LLC lifted its holdings in Axcelis Technologies by 348.9% during the second quarter. Signaturefd LLC now owns 211 shares of the semiconductor company’s stock worth $30,000 after acquiring an additional 164 shares in the last quarter. Blue Trust Inc. lifted its holdings in Axcelis Technologies by 223.8% during the second quarter. Blue Trust Inc. now owns 272 shares of the semiconductor company’s stock worth $39,000 after acquiring an additional 188 shares in the last quarter. Ashton Thomas Private Wealth LLC bought a new position in Axcelis Technologies during the second quarter worth about $39,000. Meeder Asset Management Inc. bought a new position in Axcelis Technologies during the second quarter worth about $69,000. Finally, Truvestments Capital LLC acquired a new stake in shares of Axcelis Technologies in the 3rd quarter valued at about $69,000. 89.98% of the stock is currently owned by institutional investors.

Axcelis Technologies Price Performance

NASDAQ:ACLS opened at $73.51 on Friday. The company has a debt-to-equity ratio of 0.04, a quick ratio of 3.29 and a current ratio of 4.45. The stock’s 50-day simple moving average is $90.00 and its 200 day simple moving average is $110.16. The company has a market cap of $2.39 billion, a P/E ratio of 10.87, a P/E/G ratio of 2.41 and a beta of 1.60. Axcelis Technologies, Inc. has a 52-week low of $69.35 and a 52-week high of $158.61.

Analyst Upgrades and Downgrades

Several research firms have issued reports on ACLS. B. Riley dropped their price target on Axcelis Technologies from $190.00 to $165.00 and set a “buy” rating on the stock in a research note on Friday, August 2nd. Benchmark downgraded Axcelis Technologies from a “buy” rating to a “hold” rating in a research note on Friday, November 8th. Finally, Needham & Company LLC reissued a “hold” rating on shares of Axcelis Technologies in a research note on Friday, November 8th. Three analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. Based on data from MarketBeat, Axcelis Technologies has a consensus rating of “Moderate Buy” and an average price target of $167.33.

Axcelis Technologies Company Profile

Axcelis Technologies, Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia Pacific. The company offers high energy, high current, and medium current implanters for various application requirements.